The US biotechnology industry: industry dynamics and policy

The inseparability of the biotechnology industry and the state is a central theme in the analysis of the location and performance of biotechnology industry in the US and elsewhere. This paper reports on the results of a survey of US biotechnology companies looking particularly at their assessment of needs, barriers, strategies, and government programs. The paper shows that although there is an increasing level of federal and state intervention, there are considerable barriers faced by biotechnology firms, which may or may not be resolved in the near future because of the nature of the business of biotechnology, which involves uncertainties at every stage of innovation and commercialisation.